FDAnews Drug Daily Bulletin

RECEPTOPHARM SIGNS LETTER OF INTENT TO BE AQUIRED BY NUTRA PHARMA CORPORATION

June 20, 2006
A A

Nutra Pharma Corp., a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced that ReceptoPharm has signed a letter of intent to be fully acquired by Nutra Pharma Corp.
Genetic Engineering News